AREC — Arecor Therapeutics Share News
0.000.00%
Last trade - 00:00- £37.37m
- £34.28m
- £1.71m
Brief: Arecor Therapeutics Reports FY Total Group Revenue Of £4.6 Million
Arecor Therapeutics - Year End Trading Update
Arecor Therapeutics - Arecor announces update on INBRX-101
Brief: Arecor Therapeutics Announces Expansion Of Formulation Study Collaboration With Pharma Division Of A Chemicals Marketing & Pharma Co
Arecor Therapeutics - Agreement with global medical products company
Brief: Arecor Therapeutics Says Signed Further Collaboration Agreement With Eli Lilly And Co
Arecor Therapeutics - Product with Arestat technology launched in Europe
Brief: Arecor Therapeutics Updates on Progress Of Phase I Clinical Study Of At278
RCS - Arecor Therapeutics - Arecor on Investor Meet Company Platform
Brief: Arecor Therapeutics HY Revenue Of £1.7 Million Increased By 141%
Arecor Therapeutics - Interim Results for six months ended 30 June 2023
Brief: Arecor Therapeutics Says Hikma Communicated Its Intention To Continue Development Of At307
RCS - Arecor Therapeutics - TETRIS PHARMA ANNOUNCES AGREEMENT WITH GOODLIFE
Arecor Therapeutics - Notice of Interim Results
Brief: Arecor Therapeutics Says Cash Position At June 30 Of 8.2 Mln Stg
Arecor Therapeutics - Arecor Business Update
Brief: Arecor Therapeutics Enters Into Agreement With Leading Biopharmaceutical Company
Arecor Therapeutics - Additional Agreement with Leading Biopharma
Brief: Arecor Therapeutics Says Granted Key Patents In Europe And China